SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 16th, 2017 • Rennova Health, Inc. • Services-testing laboratories • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of March 15, 2017, between Rennova Health, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITY AGREEMENTSecurity Agreement • March 16th, 2017 • Rennova Health, Inc. • Services-testing laboratories • New York
This SECURITY AGREEMENT, dated as of March __, 2017 (this “Agreement”), is among Rennova Health, Inc., a Delaware corporation (the “Company”), all of the Subsidiaries of the Company (such subsidiaries, the “Guarantors” and together with the Company, the “Debtors”) and the holders of the Company’s Original Issue Discount Senior Secured Convertible Debentures due two years following their issuance, in the original aggregate principal amount of up to $17,360,000 (collectively, the “Debentures”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”).
SUBSIDIARY GUARANTEESubsidiary Guarantee • March 16th, 2017 • Rennova Health, Inc. • Services-testing laboratories • New York
SUBSIDIARY GUARANTEE, dated as of March __, 2017 (this “Guarantee”), made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the purchasers and investors, as applicable, signatory (together with their permitted assigns, the “Purchasers”) to that certain Securities Purchase Agreement (“Purchase Agreement”), dated as of the date hereof, between Rennova Health, Inc., a Delaware corporation (the “Company”) and the purchasers and those certain Securities Exchange Agreements (“Exchange Agreements”), dated as of the date hereof, by and between the Company and the investors signatory thereto.
EXCHANGE AGREEMENTExchange Agreement • March 16th, 2017 • Rennova Health, Inc. • Services-testing laboratories • New York
EXCHANGE AGREEMENT (the “Agreement”) is made as of the 15th day of March 2017, by and between Rennova Health, Inc., a Delaware corporation (the “Company”), and the investor signatory hereto (the “Investor”).
SERIES [A/B/C] COMMON STOCK PURCHASE WARRANT rENNOVA HEALTH, INC.Rennova Health, Inc. • March 16th, 2017 • Services-testing laboratories
THIS SERIES [A/B/C] COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the _____[2] year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rennova Health, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock [;provided, however, the exercisability of this Series C Warrant shall vest ratably from time to time in proportion to the Holder’s (or its permitted assigns) exercise of the Series B Common Stock Purchase Warrant as compared with all Series B Common Stock Purchase Warrants issued to Holder at the Closing (“Vesting Schedule”). No
